These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9025234)

  • 41. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA; Hasan F; Ahmed S; Hameed A
    Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants.
    Mett H; Rosta S; Schacher B; Frei R
    Rev Infect Dis; 1988; 10(4):765-9. PubMed ID: 3263685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Channel-tunnels: outer membrane components of type I secretion systems and multidrug efflux pumps of Gram-negative bacteria.
    Andersen C
    Rev Physiol Biochem Pharmacol; 2003; 147():122-65. PubMed ID: 12783268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ushers and secretins: channels for the secretion of folded proteins across the bacterial outer membrane.
    Thanassi DG
    J Mol Microbiol Biotechnol; 2002 Jan; 4(1):11-20. PubMed ID: 11763968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural outer membrane permeabilizers boost antibiotic action against irradiated resistant bacteria.
    Farrag HA; Abdallah N; Shehata MMK; Awad EM
    J Biomed Sci; 2019 Sep; 26(1):69. PubMed ID: 31500622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002).
    Jones RN; Deshpande LM; Bell JM; Turnidge JD; Kohno S; Hirakata Y; Ono Y; Miyazawa Y; Kawakama S; Inoue M; Hirata Y; Toleman MA
    Diagn Microbiol Infect Dis; 2004 Aug; 49(4):289-94. PubMed ID: 15313535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase.
    Zhao WH; Asano N; Hu ZQ; Shimamura T
    J Pharm Pharmacol; 2003 Jun; 55(6):735-40. PubMed ID: 12841932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiantibiotic resistance caused by active drug extrusion in Pseudomonas aeruginosa and other gram-negative bacteria.
    Nakae T
    Microbiologia; 1997 Sep; 13(3):273-84. PubMed ID: 9353746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accelerating whole-cell biocatalysis by reducing outer membrane permeability barrier.
    Ni Y; Chen RR
    Biotechnol Bioeng; 2004 Sep; 87(6):804-11. PubMed ID: 15329939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria.
    Bolla JM; Alibert-Franco S; Handzlik J; Chevalier J; Mahamoud A; Boyer G; Kieć-Kononowicz K; Pagès JM
    FEBS Lett; 2011 Jun; 585(11):1682-90. PubMed ID: 21549704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Guides for rational use of B-lactam antibiotics:resistance mechanism and clinical interpretation].
    Arias CA; Panesso D; Zúñiga M
    Biomedica; 2003 Jun; 23(2):134-40. PubMed ID: 12872552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical implications of antibiotic resistance.
    Quinn JP
    Pharmacotherapy; 1992; 12(5):391-6. PubMed ID: 1331994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mobile gene cassettes and DNA integration elements ].
    Kovalevskaia NP
    Mol Biol (Mosk); 2002; 36(2):261-7. PubMed ID: 11969087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modification by analgesics of the susceptibility to antibiotics in Serratia marcescens.
    Puig M; Palomar J; Lorén JG; Viñas M
    New Microbiol; 1995 Oct; 18(4):385-90. PubMed ID: 8590391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efflux-mediated antibiotics resistance in bacteria].
    Cattoir V
    Pathol Biol (Paris); 2004 Dec; 52(10):607-16. PubMed ID: 15596311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug efflux as a mechanism of resistance.
    Williams JB
    Br J Biomed Sci; 1996 Dec; 53(4):290-3. PubMed ID: 9069107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Unravelling the mechanisms of the biogenesis of the outer membrane of Gram-negative bacteria: a step toward the development of new antibiotics].
    Collet JF
    Bull Mem Acad R Med Belg; 2009; 164(7-9):213-20; discussion 220. PubMed ID: 20218188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Resistance to antibiotics caused by decrease of the permeability in gram-negative bacteria].
    Nguyen Van JC; Gutmann L
    Presse Med; 1994 Mar; 23(11):522, 527-31. PubMed ID: 8022741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.